Intensity Therapeutics Analyst Ratings
BenzingaMar 21 22:03
Intensity Therapeutics Analyst Ratings
BenzingaNov 14, 2023 22:24
Benchmark Reiterates Speculative Buy on Intensity Therapeutics, Maintains $12 Price Target
BenzingaAug 24, 2023 20:52
Intensity Therapeutics Analyst Ratings
BenzingaAug 24, 2023 20:51
Benchmark Initiates Coverage On Intensity Therapeutics With Speculative Buy Rating, Announces Price Target of $12
BenzingaJul 18, 2023 18:56
Intensity Therapeutics Analyst Ratings
BenzingaJul 18, 2023 18:56
No Data
No Data